These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11021018)

  • 1. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
    Yoshihara S; Yamada Y; Abe T; Arisaka O
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
    [No Abstract]   [Full Text] [Related]  

  • 3. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
    Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma.
    Rühle KH; Dorow P; Schmitz-Schumann H
    Lung; 1990; 168 Suppl():192-3. PubMed ID: 1974676
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
    Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
    J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
    Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
    Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
    Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
    Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
    Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of oral tulobuterol on bronchial obstruction in asthmatic patients].
    Vergeret J; Taytard A
    Therapie; 1988; 43(1):21-4. PubMed ID: 3358248
    [No Abstract]   [Full Text] [Related]  

  • 12. Cough variant and cough-predominant asthma are major causes of persistent cough: a multicenter study in Japan.
    Niimi A; Ohbayashi H; Sagara H; Yamauchi K; Akiyama K; Takahashi K; Inoue H; Wakayama T; Kobayashi H; Hasegawa M; Kimura G; Yokoe T; Adachi M
    J Asthma; 2013 Nov; 50(9):932-7. PubMed ID: 23841529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
    Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
    Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homemade spacers useful in asthma treatment.
    Richardson CR
    J Fam Pract; 1999 Dec; 48(12):997. PubMed ID: 10628581
    [No Abstract]   [Full Text] [Related]  

  • 15. Can oral beta2 agonists cause heart failure?
    Jenne JW
    Lancet; 1998 Oct; 352(9134):1081-2. PubMed ID: 9798578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function.
    Kume H; Kondo M; Ito Y; Suzuki R; Yamaki K; Takagi K
    Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1076-83. PubMed ID: 12390295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
    Lin Q; Liu QH; Bao YX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tulobuterol in the management of obstructive airways disease in adults.
    Patel KR
    Clin Ther; 1985; 7(4):452-67. PubMed ID: 2861899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis.
    Patel KR
    Lung; 1990; 168 Suppl():210-8. PubMed ID: 1974679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.